Tumor necrosis factor (TNF) is produced as a membrane-bound, 26-kDa proform from which the mature, 17-kDa TNF subunit is released by proteolytic cleavage. In order to compare the biological activity of membrane-bound versus soluble TNF, mutational analysis of potential cleavage sites in murine TNF was carried out. The biological activity was assessed after transfection in L929 cells. Deletion of the first nine codons of the mature part of the murine TNF gene still led to the production of secretable TNF, indicating alternative cleavage sites separate from the -1/+1 junction. However, an additional deletion of 3 amino acids, generating TNF1-12, resulted in a membrane-bound form of TNF. Site-directed mutagenesis revealed Lys as the critical residue for alternative cleavage. Mutation of this residue to Glu in a TNF1-9 mutant gave rise to uncleavable, membrane-bound TNF with biological activities similar to wild-type TNF. Induction of apoptosis, proliferation, or cytokine production by triggering of either 55-kDa or 75-kDa TNF receptors in appropriate cell lines occurred efficiently both with soluble and with membrane-bound TNF. The latter was, however, less active in the cytotoxic assays on U937 cells in which the 75-kDa TNF receptor is not signaling, but contributes to maximal TNF activity by ligand passing. This indicates that membrane-bound TNF cannot be passed from the 75-kDa to the 55-kDa TNF receptor.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				G. Rajashekhar, M. Grow, A. Willuweit, C. E. Patterson, and M. Clauss Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation Physiol Genomics, September 11, 2007; 31(1): 104 - 113. [Abstract] [Full Text] [PDF]

				J. Zalevsky, T. Secher, S. A. Ezhevsky, L. Janot, P. M. Steed, C. O'Brien, A. Eivazi, J. Kung, D.-H. T. Nguyen, S. K. Doberstein, et al. Dominant-Negative Inhibitors of Soluble TNF Attenuate Experimental Arthritis without Suppressing Innate Immunity to Infection J. Immunol., August 1, 2007; 179(3): 1872 - 1883. [Abstract] [Full Text] [PDF]

				M. B. Olszewski, A. J. Groot, J. Dastych, and E. F. Knol TNF Trafficking to Human Mast Cell Granules: Mature Chain-Dependent Endocytosis J. Immunol., May 1, 2007; 178(9): 5701 - 5709. [Abstract] [Full Text] [PDF]

				X. Valencia, C. Yarboro, G. Illei, and P. E. Lipsky Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus J. Immunol., February 15, 2007; 178(4): 2579 - 2588. [Abstract] [Full Text] [PDF]

				X. Valencia, G. Stephens, R. Goldbach-Mansky, M. Wilson, E. M. Shevach, and P. E. Lipsky TNF downmodulates the function of human CD4+CD25hi T-regulatory cells Blood, July 1, 2006; 108(1): 253 - 261. [Abstract] [Full Text] [PDF]

				J. G. Kay, R. Z. Murray, J. K. Pagan, and J. L. Stow Cytokine Secretion via Cholesterol-rich Lipid Raft-associated SNAREs at the Phagocytic Cup J. Biol. Chem., April 28, 2006; 281(17): 11949 - 11954. [Abstract] [Full Text] [PDF]

				M. Faber, M. Bette, M. A. R. Preuss, R. Pulmanausahakul, J. Rehnelt, M. J. Schnell, B. Dietzschold, and E. Weihe Overexpression of Tumor Necrosis Factor Alpha by a Recombinant Rabies Virus Attenuates Replication in Neurons and Prevents Lethal Infection in Mice J. Virol., December 15, 2005; 79(24): 15405 - 15416. [Abstract] [Full Text] [PDF]

				R. Guler, M. L. Olleros, D. Vesin, R. Parapanov, and I. Garcia Differential Effects of Total and Partial Neutralization of Tumor Necrosis Factor on Cell-Mediated Immunity to Mycobacterium bovis BCG Infection Infect. Immun., June 1, 2005; 73(6): 3668 - 3676. [Abstract] [Full Text] [PDF]

				N. Askenasy, E. S. Yolcu, I. Yaniv, and H. Shirwan Induction of tolerance using Fas ligand: a double-edged immunomodulator Blood, February 15, 2005; 105(4): 1396 - 1404. [Abstract] [Full Text] [PDF]

				H. Xu, J. Hirosumi, K. T. Uysal, A. D. Guler, and G. S. Hotamisligil Exclusive Action of Transmembrane TNF{alpha} in Adipose Tissue Leads to Reduced Adipose Mass and Local But Not Systemic Insulin Resistance Endocrinology, April 1, 2002; 143(4): 1502 - 1511. [Abstract] [Full Text] [PDF]

				M. L. Olleros, R. Guler, N. Corazza, D. Vesin, H.-P. Eugster, G. Marchal, P. Chavarot, C. Mueller, and I. Garcia Transmembrane TNF Induces an Efficient Cell-Mediated Immunity and Resistance to Mycobacterium bovis Bacillus Calmette-Guerin Infection in the Absence of Secreted TNF and Lymphotoxin-{alpha} J. Immunol., April 1, 2002; 168(7): 3394 - 3401. [Abstract] [Full Text] [PDF]

				S. Majka, P. G. McGuire, and A. Das Regulation of Matrix Metalloproteinase Expression by Tumor Necrosis Factor in a Murine Model of Retinal Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 260 - 266. [Abstract] [Full Text] [PDF]

				R C Newton, K A Solomon, M B Covington, C P Decicco, P J Haley, S M Friedman, and K Vaddi Biology of TACE inhibition Ann Rheum Dis, November 1, 2001; 60(90003): iii25 - 32. [Abstract] [Full Text] [PDF]

				A. Willuweit, G. Sass, A. Schoneberg, U. Eisel, G. Tiegs, and M. Clauss Chronic Inflammation and Protection from Acute Hepatitis in Transgenic Mice Expressing TNF in Endothelial Cells J. Immunol., October 1, 2001; 167(7): 3944 - 3952. [Abstract] [Full Text] [PDF]

				J. G. Conway, R. C. Andrews, B. Beaudet, D. M. Bickett, V. Boncek, T. A. Brodie, R. L. Clark, R. C. Crumrine, M. A. Leenitzer, D. L. McDougald, et al. Inhibition of Tumor Necrosis Factor-alpha (TNF-alpha ) Production and Arthritis in the Rat by GW3333, a Dual Inhibitor of TNF-alpha -Converting Enzyme and Matrix Metalloproteinases J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 900 - 908. [Abstract] [Full Text]

				K. Tanaka, G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport Evidence that Cleavage of the Thyrotropin Receptor Involves a "Molecular Ruler" Mechanism: Deletion of Amino Acid Residues 305-320 Causes a Spatial Shift in Cleavage Site 1 Independent of Amino Acid Motif Endocrinology, October 1, 2000; 141(10): 3573 - 3577. [Abstract] [Full Text] [PDF]

				M. Quinones, S. K. Ahuja, P. C. Melby, L. Pate, R. L. Reddick, and S. S. Ahuja Preformed Membrane-associated Stores of Interleukin (IL)-12 Are a Previously Unrecognized Source of Bioactive IL-12 That Is Mobilized within Minutes of Contact with an Intracellular Parasite J. Exp. Med., August 14, 2000; 192(4): 507 - 516. [Abstract] [Full Text] [PDF]

				A. J. Meszaros, J. S. Reichner, and J. E. Albina Macrophage-Induced Neutrophil Apoptosis J. Immunol., July 1, 2000; 165(1): 435 - 441. [Abstract] [Full Text] [PDF]

				C. Mueller, N. Corazza, S. Trachsel-Loseth, H.-P. Eugster, M. Buhler-Jungo, T. Brunner, and M. A. Imboden Noncleavable Transmembrane Mouse Tumor Necrosis Factor-alpha (TNFalpha ) Mediates Effects Distinct from Those of Wild-type TNFalpha in Vitro and in Vivo J. Biol. Chem., December 31, 1999; 274(53): 38112 - 38118. [Abstract] [Full Text] [PDF]

				H. Xu, J. K. Sethi, and G. S. Hotamisligil Transmembrane Tumor Necrosis Factor (TNF)-alpha Inhibits Adipocyte Differentiation by Selectively Activating TNF Receptor 1 J. Biol. Chem., September 10, 1999; 274(37): 26287 - 26295. [Abstract] [Full Text] [PDF]

				B. Han and G. D. Fischbach The Release of Acetylcholine Receptor Inducing Activity (ARIA) from Its Transmembrane Precursor in Transfected Fibroblasts J. Biol. Chem., September 10, 1999; 274(37): 26407 - 26415. [Abstract] [Full Text] [PDF]

				E. Haas, M. Grell, H. Wajant, and P. Scheurich Continuous Autotropic Signaling by Membrane-expressed Tumor Necrosis Factor J. Biol. Chem., June 18, 1999; 274(25): 18107 - 18112. [Abstract] [Full Text] [PDF]

				E. Decoster, B. Vanhaesebroeck, E. Boone, S. Plaisance, K. De Vos, G. Haegeman, J. Grooten, and W. Fiers Induction of Unresponsiveness to Tumor Necrosis Factor (TNF) after Autocrine TNF Expression Requires TNF Membrane Retention J. Biol. Chem., February 6, 1998; 273(6): 3271 - 3277. [Abstract] [Full Text] [PDF]

				P. Deng, C. W. Rettenmier, and P. K. Pattengale Structural Requirements for the Ectodomain Cleavage of Human Cell Surface Macrophage Colony-stimulating Factor J. Biol. Chem., July 5, 1996; 271(27): 16338 - 16343. [Abstract] [Full Text] [PDF]

				C.-L. Tsou, C. A. Haskell, and I. F. Charo Tumor Necrosis Factor-alpha -converting Enzyme Mediates the Inducible Cleavage of Fractalkine J. Biol. Chem., November 21, 2001; 276(48): 44622 - 44626. [Abstract] [Full Text] [PDF]

				M. Ryden, A. Dicker, V. van Harmelen, H. Hauner, M. Brunnberg, L. Perbeck, F. Lonnqvist, and P. Arner Mapping of Early Signaling Events in Tumor Necrosis Factor-alpha -mediated Lipolysis in Human Fat Cells J. Biol. Chem., January 4, 2002; 277(2): 1085 - 1091. [Abstract] [Full Text] [PDF]